A 6-protein blood-based model predicted kidney function decline in patients with ADPKD more accurately than clinical or imaging-based models, and offers a new pathway for outcome prediction.
The FDA has granted Breakthrough Device designation to Castle Biosciences’ DecisionDx-Melanoma test, a gene expression profile assay designed to improve risk stratification and personalized care in cutaneous melanoma.
As public awareness rises, doctors are being called to bridge the knowledge gap, offer screening, and guide patients through complex and evolving risks.
A new study identified human pegivirus in the brains and blood of patients with Parkinson’s disease, revealing virus-linked immune and gene expression changes that varied by genetic background.
Scientists engineered E. coli to perform a synthetic chemical reaction that enables the conversion of plastic waste into the common drug paracetamol using a non-toxic, phosphate-driven process inside living cells.
A new study found that genetic differences in the AMY1 gene, which affects salivary amylase production, along with dietary starch, influence the types and diversity of bacteria that form in oral biofilms—key players in dental caries and gum disease.
Vitamin C may help thicken human skin by epigenetically activating genes involved in cell growth, according to new research using a lab-grown human skin model. The study found that vitamin C, or L-ascorbic acid, promotes epidermal proliferation by modifying gene activity through DNA demethylation.